文献速递血栓与止血贫血与红细胞疾病

COVID-19后迟发性血液学并发症:血液科医生面临的新兴医学问题

Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.
PubMed 文献 · Am J Hematol · 2021-11-08

本文综述COVID-19急性期后迟发性血液学并发症的现有证据。COVID-19诱导的凝血病(免疫血栓状态)与血栓栓塞和出血事件相关,免疫失调相关的迟发性血小板减少症为罕见表现。密切监测实验室动态对及时发现需进一步检查的异常值至关重要,血液科医生在多学科长新冠管理中起关键作用。

要点

  • COVID-19诱导的凝血病(免疫血栓状态)与血栓栓塞和出血事件相关。
  • 免疫失调相关的迟发性血小板减少症是COVID-19后罕见表现。
  • 密切监测实验室动态以识别需进一步检查的异常值并及时给予支持治疗。

核心结论

  • COVID-19后迟发性血液学并发症是血液科医生面临的新兴医学问题,血液科医生在多学科长新冠管理中起关键作用。

主要发现

  • COVID-19诱导的凝血病(免疫血栓状态)与血栓栓塞和出血事件相关。
  • 免疫失调相关的迟发性血小板减少症被报道为COVID-19后罕见表现。

临床怎么用

  • 密切监测实验室动态以识别需进一步检查的异常值,并在有指征时提供支持治疗。
  • 血液科医生应参与长新冠的多学科管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus disease 19 (COVID-19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematological disorders. COVID-19-induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late-onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Korompoki E, Gavriatopoulou M, Fotiou D, et al. Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist. Am J Hematol. 2021. PMID: 34687462. doi:10.1002/ajh.26384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。